Institute For Medical Education and Research (IMER)

oncology melanoma md cancer ipilimumab cml metastatic breast cancer immuno-oncology phd endocrinopathies chronic myelogenous leukemia braf inhibitor imatinib prostate cancer bevacizumab docetaxel ovarian ovarian cancer immune-related adverse events. vaccines immunotherapies non-small cell lung cancer anti-ctla-4 renal cell carcinoma her2 positive anthracyclines hormonal therapy her2+ her2-targeted therapy endocrine therapy adjuvant therapy receptor targeted therapy positive aromatase inhibitors advanced pi3k/mtor inhibitors combination therapy estrogen endocrine-resistance vegf pathway antiangiogenic agents antiangiogenesis pdgf therapies fgf vegf antiangiogenic iraes imer gi dacarbazine mek inhibitors braf ctla4 inhibitors antoni ribas md cancer care john powderly ii androgen-ablation charles g. drake imiquimod cd8+ cytotoxic t lymphocyte prostate ctla-4 tlr ligands tumor antigens tremelimumab thomas f. gajewski jorge e. cortes jerald p. radich michael wn deininger evan m. hersh md mapk pathway hypophysitis kaplan-meier analysis peg esper mdx010-20 krista m. rubin vemurafenib sokal hasford scoresdasatinib ipilimumab tyrosine kinase inhibitors tkis dasatinib nilotinib kathleen k. curran mollie e. moran michael r. savona philadelphia chromosome anti-ctla4 antibody perifosine/bortezomib lenalidomide venous thromboembolic events gcsf bortezomib vte calgb 100104 schema maintenance therapy cyclophosphamide pat killingsworth crab page bertolotti sundar jagannath beth faiman hypogammaglobulinemia multiple myeloma so325 trial design iris study fish cytogenetic response tops trial mutational analysis chronic michael w. n. deininger leukemia myelogenous bcr-abl hpv status anti-angiogenic agents egfr inhibitors hnc marshall r. posner head and neck dexamethasone emmanuel antonarakis abiraterone dr. a. oliver sartor cabazitaxel leonard gomella immunotherapy sipuleucel-t prospect trial tropic trial diphenhydramine ketoconazole tax 327 crpc cabazitaxel-prednisone swog 9916 castration-resistant maurie markman md cisplatin carboplatin vismodegib hedgehog inhibitor basal cell carcinoma jean y. tang bcc